A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI)

Author:

Yule AlexanderORCID,Ng ChristabellaORCID,Recto Arantxa,Lockwood FlorenceORCID,Dellschaft Neele S,Hoad Caroline LORCID,Zagoya Carlos,Mainz Jochen G,Major GilesORCID,Barr Helen L,Gowland Penny AORCID,Stewart Iain,Marciani LucaORCID,Spiller Robin CORCID,Smyth Alan RORCID

Funder

Vertex Pharmaceuticals Incorporated

Publisher

Elsevier BV

Reference30 articles.

1. Thinking outside the box: a review of gastrointestinal symptoms and complications in cystic fibrosis;Yule;Expert Rev Respir Med,2023

2. A grumbling concern: a survey of gastrointestinal symptoms in cystic fibrosis in the modulator era [version 2; peer review: 2 approved, 3 approved with reservations];Calthorpe;NIHR Open Res,2024

3. How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey;Smith;BMJ Open Respir Res,2020

4. Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis;Moshiree;J Cyst Fibros,2023

5. A refresh of the top 10 research priorities in cystic fibrosis;Rowbotham;Thorax,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3